CareDx EPS - Earnings per Share 2013-2025 | CDNA

CareDx eps - earnings per share from 2013 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
CareDx Annual EPS
2024 $0.93
2023 $-3.54
2022 $-1.44
2021 $-0.59
2020 $-0.40
2019 $-0.52
2018 $-1.31
2017 $-2.38
2016 $-2.39
2015 $-1.16
2014 $0.10
2013 $-3.50
2012 $-5.01
CareDx Quarterly EPS
2025-03-31 $-0.19
2024-12-31 $1.48
2024-09-30 $-0.14
2024-06-30 $-0.03
2024-03-31 $-0.38
2023-12-31 $-2.21
2023-09-30 $-0.43
2023-06-30 $-0.46
2023-03-31 $-0.44
2022-12-31 $-0.34
2022-09-30 $-0.32
2022-06-30 $-0.41
2022-03-31 $-0.37
2021-12-31 $-0.31
2021-09-30 $-0.23
2021-06-30 $-0.04
2021-03-31 $-0.01
2020-12-31 $-0.05
2020-09-30 $-0.06
2020-06-30 $-0.15
2020-03-31 $-0.14
2019-12-31 $-0.11
2019-09-30 $-0.04
2019-06-30 $-0.19
2019-03-31 $-0.18
2018-12-31 $-0.07
2018-09-30 $-0.54
2018-06-30 $-0.40
2018-03-31 $-0.30
2017-12-31 $-1.30
2017-09-30 $-0.63
2017-06-30 $-0.19
2017-03-31 $-0.26
2016-12-31 $-0.55
2016-09-30 $-0.26
2016-06-30 $-0.77
2016-03-31 $-0.81
2015-12-31 $-0.41
2015-09-30 $-0.29
2015-06-30 $-0.27
2015-03-31 $-0.19
2014-12-31 $1.14
2014-09-30 $0.12
2014-06-30 $0.13
2014-03-31 $-1.29
2013-12-31 $-0.56
2013-09-30 $-0.82
2013-06-30 $-0.79
2013-03-31 $-1.33
2012-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.663B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.013B 25.51
CVS Health (CVS) United States $78.381B 9.74
Elevance Health (ELV) United States $62.395B 8.39
Cencora (COR) United States $56.765B 19.75
DiDi Global (DIDIY) China $26.874B 28.55
Labcorp Holdings (LH) United States $20.399B 16.55
Natera (NTRA) United States $18.966B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.991B 0.00
CochLear (CHEOY) Australia $13.143B 0.00
Solventum (SOLV) United States $12.678B 13.42
ICON (ICLR) Ireland $11.592B 10.78
Revvity (RVTY) United States $10.993B 18.92
Viatris (VTRS) United States $10.422B 3.58
Avantor (AVTR) United States $9.056B 13.16
Medpace Holdings (MEDP) United States $8.964B 23.81
Sonic Healthcare (SKHHY) Australia $8.852B 0.00
HealthEquity (HQY) United States $8.449B 37.01
Caris Life Sciences,�Inc (CAI) United States $7.680B 0.00
Charles River Laboratories (CRL) United States $7.587B 14.87
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.918B 28.96
BrightSpring Health Services (BTSG) United States $3.506B 32.17
Sotera Health (SHC) United States $3.139B 17.84
Surgery Partners (SGRY) United States $2.861B 37.20
Concentras Parent (CON) United States $2.507B 14.49
Organon (OGN) United States $2.459B 2.61
Alignment Healthcare (ALHC) United States $2.455B 0.00
GeneDx Holdings (WGS) United States $2.222B 85.57
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.823B 0.00
Premier (PINC) United States $1.725B 13.09
GoodRx Holdings (GDRX) United States $1.672B 33.43
Ardent Health (ARDT) United States $1.589B 6.77
Teladoc Health (TDOC) United States $1.412B 0.00
QDM (QDMI) Hong Kong, SAR China $1.277B 438.00
Establishment Labs Holdings (ESTA) $1.202B 0.00
Pediatrix Medical (MD) United States $1.080B 8.22
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.878B 0.00
AMN Healthcare Services Inc (AMN) United States $0.759B 7.10
Nutex Health (NUTX) United States $0.632B 9.57
So-Young (SY) China $0.595B 0.00
SBC Medicals (SBC) United States $0.585B 0.00
Embecta (EMBC) United States $0.572B 3.85
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.479B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
Sonida Senior Living (SNDA) United States $0.466B 0.00
Omada Health (OMDA) $0.453B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.402B 0.00
Enhabit (EHAB) United States $0.342B 28.12
Oncology Institute (TOI) United States $0.312B 0.00
Performant Healthcare (PHLT) United States $0.297B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Pheton Holdings (PTHL) China $0.146B 0.00
DocGo (DCGO) United States $0.146B 23.83
Sera Prognostics (SERA) United States $0.110B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
KindlyMD (NAKA) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Biodesix (BDSX) United States $0.047B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
ModivCare (MODV) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.043B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00